Dr. Reddy's Laboratories, Inc. Recall: Ranitidine Tablets, USP 150 mg, a.) 65 count bottle
Dr. Reddy's Laboratories, Inc. Recall: Ranitidine Tablets, USP 150 mg, a.) 65 count bottle is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Dr. Reddy's Laboratories, Inc.; Product: Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 130 count bottles (NDC 49035-4
| Recalling firm | Dr. Reddy's Laboratories, Inc. |
|---|---|
| Product | Ranitidine Tablets, USP 150 mg, a.) 65 count bottles (NDC 49035-404-61) b.) 130 count bottles (NDC 49035-404-13) c.) 220 count bottles (NDC 49035-404-65) (Walmart) OTC |
| Reason for recall | CGMP Deviations: Presence of NDMA impurity detected in product. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Completed |
| Distribution | Product was distributed to major distributors throughout the United States who may have further distributed the product. |
| Recall initiated | 20191001 |
| Recall number | D-0171-2020 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →